-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
Source: NASDAQ US Markets / 18 Mar 2024 07:40:23 America/New_York
(RTTNews) - AstraZeneca (AZN.L, AZN) said it will expand the savings programs for entire US inhaled respiratory portfolio. The company said, starting June 1, 2024, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines, includin https://www.nasdaq.com/articles/astrazeneca-to-expand-savings-programs-for-us-inhaled-respiratory-portfolio